Replies to post #18224 on Intellipharmaceutics International Inc. (IPCI)

[WeeZuhl]

Oh, I've seen it. BIG problems here.

lmfao try reading their recently released food effects PR

The study design was a randomized, one-treatment two periods, two sequences, crossover, open label, laboratory-blind bioavailability study for RexistaTM XR following a single 80 mg oral dose to healthy adults under fasting and fed conditions.

Uh oh. A single dose to healthy adults. Blue dye's deadly effects are associated with illness and change in gut permeability. Don't sweat it- maybe no Rexista users will ever become septic.


Both IPCI and FDA are going to regret not doing a Safety & Efficacy Phase 3 study on this ticking time bomb. (Or will they?)